Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Tactile Systems Technology ( (TCMD) ) has provided an announcement.
On May 6, 2026, Tactile Systems Technology stockholders elected nine directors, including William W. Burke, Valerie L. Asbury, and others, to serve until the 2027 annual meeting or until successors are duly elected and qualified. Shareholders also ratified Grant Thornton LLP as the independent auditor for the year ending Dec. 31, 2026, and approved on an advisory basis the compensation of named executive officers.
At the same meeting, investors backed an amendment to the company’s Amended and Restated Certificate of Incorporation to allow director removal in a manner consistent with Delaware law. These governance and compensation approvals reinforce the company’s existing leadership structure, validate its audit oversight, and provide added flexibility in board accountability mechanisms for shareholders going forward.
The most recent analyst rating on (TCMD) stock is a Buy with a $36.00 price target. To see the full list of analyst forecasts on Tactile Systems Technology stock, see the TCMD Stock Forecast page.
Spark’s Take on TCMD Stock
According to Spark, TipRanks’ AI Analyst, TCMD is a Neutral.
The score is held back primarily by weak cash flow quality in the latest year and bearish technicals (below key moving averages with negative MACD). Offsetting positives are a strong balance sheet with low leverage and a constructive earnings outlook featuring raised revenue guidance and improving margins/adjusted EBITDA trajectory, while valuation remains on the expensive side with no dividend support.
To see Spark’s full report on TCMD stock, click here.
More about Tactile Systems Technology
Tactile Systems Technology operates in the medical technology industry, focusing on therapeutic devices and related solutions, primarily for patients with chronic diseases and vascular conditions. The company targets healthcare providers and patients requiring specialized at-home treatment technologies, positioning itself within the broader medical devices and home healthcare markets.
Average Trading Volume: 349,100
Technical Sentiment Signal: Buy
Current Market Cap: $570.7M
For detailed information about TCMD stock, go to TipRanks’ Stock Analysis page.